Dr. Grewal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-2000
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalResidency, Nuclear Medicine, 2000 - 2002
Dayanand Medical College Class of 1996
Certifications & Licensure
NJ State Medical License 2007 - 2025
NY State Medical License 2002 - 2025
PA State Medical License 2000 - 2002- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer Start of enrollment: 2006 Jan 01
- Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma Start of enrollment: 2005 Mar 01
- Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma Start of enrollment: 2018 Aug 21
- Join now to see all
Publications & Presentations
PubMed
- 90 citationsIn differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyrogl...Fernanda Vaisman, Hernán Tala, Ravinder K. Grewal, R. Michael Tuttle
Thyroid. 2011-12-02 - 9 citationsAssessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management.Sonia Mahajan, Ravinder K Grewal, Kent P Friedman, Heiko Schöder, Neeta Pandit-Taskar
Translational Oncology. 2022-07-01 - 8 citationsEvaluation of response to induction chemotherapy in esophageal cancer: is barium esophagography or PET-CT useful?Chee Way Eng, James L. Fuqua, Ravinder K. Grewal, David H. Ilson, Antoine Messiah
Clinical Imaging. 2013-05-01
Journal Articles
- Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersSteven M Larson, Sofia Haque, Duan Li, R Michael Tuttle, Mona M Sabra, Alan L Ho, Eric J Sherman, Ravinder K Grewal, James A Fagin, David G Pfister, Ronald A Ghossein, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
Las Vegas Is Waking up. This California Town on the Road There Is Struggling to Come Back to LifeJune 16th, 2020
Theranostics with RAI Offer a Precision Approach to Treating Differentiated Thyroid CancerJuly 29th, 2019
Abstracts for the Society of Nuclear Medicine and Molecular Imaging, Greater New York and New England Chapters, 31st Annual Northeast Regional Scientific Meeting, Mystic CT, November 3–5, 2017April 23rd, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
